Jia-Yi Chen

Integrating scRNA-seq and bulk RNA-seq to characterize immune microenvironment and construct a prognostic model for HNSCC

A prognostic model incorporating risk score, clinical stage, and age was established, showing a significant difference in overall survival between high- and low-risk groups, and a generally limited responsiveness of HNSCC to immunotherapy in the absence of specific clinical indicators.